patent/US-4963559-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4963559-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate	1982-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate	1990-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_545517c8993fb1c0883acbf9907a288e
publicationDate	1990-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	US-4963559-A
titleOfInvention	Method of treating cancer and cancer metastasis
abstract	The present invention relates to an agent for treating cancer and preventing cancer metastasis consisting of a compound selected from 5-(2-chlorobenzyl)-4,5,6,7-tetrahydro-thieneo[3,2-c]pyridine and its therapeutically acceptable acid addition salts. n The therapeutically acceptable acid addition salt is in particular the hydrochloride named Ticlopidine.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007213360-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008260749-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009227577-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7741488-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008206258-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2005250184-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7723523-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6043368-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010324038-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014087240-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7763728-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006125813-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006125815-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7803945-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009258873-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009163538-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014087240-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006125815-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9626675-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009098133-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006125813-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5562277-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009252706-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007244112-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006223763-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007259911-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005118592-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7517986-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7714135-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009270378-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7714134-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7714136-B2
priorityDate	1978-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4051141-A
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67805352 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128241576 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3108 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234672364 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396248 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5472

Total number of triples: 57.